Sepsis resulting from Enterobacter aerogenes resistant to carbapenems after liver transplantation

Hepatobiliary and Pancreatic Diseases International

Volumn 8, Issue 3, 2009, Pages 320-322

  Chen, Hao ^a   Zhang, Ying ^a   Chen, Ya Gang ^a   Yu, N Song ^a   Zheng, Shu Sen ^a   Li, Lan Juan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Carbapenem therapy; Enterobacter aerogenes; Sepsis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CARBAPENEM DERIVATIVE; FLUCONAZOLE; GANCICLOVIR; IMIPENEM; LAMIVUDINE; MEROPENEM; METHYLPREDNISOLONE; PIPERACILLIN PLUS TAZOBACTAM; TACROLIMUS; TEICOPLANIN;

ABDOMINAL DRAINAGE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BILE DUCT FISTULA; BILIRUBIN BLOOD LEVEL; BLOOD CULTURE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DISSEMINATED CANCER; DOPPLER FLOWMETRY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTION; HUMAN; LIVER ABSCESS; LIVER CANCER; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS DRAINAGE; SEPSIS; STENT; ULTRASOUND;

ADULT; CARBAPENEMS; DRUG RESISTANCE, BACTERIAL; ENTEROBACTER AEROGENES; ENTEROBACTERIACEAE INFECTIONS; HUMANS; LIVER ABSCESS; LIVER TRANSPLANTATION; MALE; MULTIPLE ORGAN FAILURE; POSTOPERATIVE CARE; SHOCK, SEPTIC;

EID: 67549140167     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Arpin C, Dubois V, Coulange L, André C, Fischer I, Noury P, et al. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in community and private health care centers. Antimicrob Agents Chemother 2003;47:3506-3514. (Pubitemid 37345711)
2. Bornet C, Davin-Regli A, Bosi C, Pages JM, Bollet C. Imipenem resistance of enterobacter aerogenes mediated by outer membrane permeability. J Clin Microbiol 2000;38:1048-1052. (Pubitemid 30140557)
3. De Gheldre Y, Maes N, Rost F, De Ryck R, Clevenbergh P, Vincent JL, et al. Molecular epidemiology of an outbreak of multidrug-resistant Enterobacter aerogenes infections and in vivo emergence of imipenem resistance. J Clin Microbiol 1997;35:152-160. (Pubitemid 26422645)
4. Allerberger F, Koeuth T, Lass-FLorl C, Dierich MP, Putensen C, Scmutzhard E, et al. Epidemiology of infections due to multiresistant Enterobacter aerogenes in a university hospital. Eur J Clin Microbiol Infect Dis 1996;15:517-521. (Pubitemid 26241709)
5. Galdbart JO, Lémann F, Ainouz D, Féron P, Lambert-Zechovsky N, Branger C. TEM-24 extended-spectrum beta-lactamase-producing Enterobacter aerogenes: long-term clonal dissemination in French hospitals. Clin Microbiol Infect 2000;6:316-323. (Pubitemid 34960224)
6. De Gheldre Y, Struelens MJ, Glupczynski Y, De Mol P, Maes N, Nonhoff C, et al. National epidemiologic surveys of Enterobacter aerogenes in Belgian hospitals from 1996 to 1998. J Clin Microbiol 2001;39:889-896.
7. Salso S, Culebras E, Andrade R, Picazo JJ. Outbreak of TEM-24-producing Enterobacter aerogenes in a Spanish hospital. Microb Drug Resist 2003;9:299-305. (Pubitemid 37048552)
8. Mammeri H, Laurans G, Eveillard M, Castelain S, Eb F. Coexistence of SHV-4- and TEM-24-producing Enterobacter aerogenes strains before a large outbreak of TEM-24-producing strains in a French hospital. J Clin Microbiol 2001;39:2184-2190. (Pubitemid 32531479)
9. Piagnerelli M, Kennes B, Brogniez Y, Deplano A, Govaerts D. Outbreak of nosocomial multidrug-resistant Enterobacter aerogenes in a geriatric unit: failure of isolation contact, analysis of risk factors, and use of pulsed-field gel electrophoresis. Infect Control Hosp Epidemiol 2000;21:651-653. (Pubitemid 30786678)
10. Dumarche P, De Champs C, Sirot D, Chanal C, Bonnet R, Sirot J. TEM derivative-producing Enterobacter aerogenes strains: dissemination of a prevalent clone. Antimicrob Agents Chemother 2002;46:1128-1131. (Pubitemid 34260367)
11. Marchandin H, Godreuil S, Darbas H, Jean-Pierre H, Jumas-Bilak E, Chanal C, et al. Extended-spectrum beta-lactamase TEM-24 in an Aeromonas clinical strain: acquisition from the prevalent Enterobacter aerogenes clone in France. Antimicrob Agents Chemother 2003;47:3994-3995. (Pubitemid 37485025)
12. Fernández-Cuenca F, Rodríguez-Martínez JM, Martínez-Martínez L, Pascual A. In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase. Int J Antimicrob Agents 2006;27:549-552.
13. Biendo M, Canarelli B, Thomas D, Rousseau F, Hamdad F, Adjide C, et al. Successive emergence of extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter aerogenes isolates in a university hospital. J Clin Microbiol 2008;46:1037-1144
14. Souli M, Kontopidou FV, Papadomichelakis E, Galani I, Armaganidis A, Giamarellou H. Clinical experience of serious infections caused by Enterobacteriaceae producing VIM-1 metallo-beta-lactamase in a Greek University Hospital. Clin Infect Dis 2008;46:847-854.
15. Chen YG, Zhang Y, Yu YS, Qu TT, Wei ZQ, Shen P, et al. In vivo development of carbapenem resistance in clinical isolates of Enterobacter aerogenes producing multiple beta-lactamases. Int J Antimicrob Agents 2008;32:302-307.
16. Thiolas A, Bollet C, La Scola B, Raoult D, Pagès JM. Successive emergence of Enterobacter aerogenes strains resistant to imipenem and colistin in a patient. Antimicrob Agents Chemother 2005;49:1354-1358. (Pubitemid 40463361)